BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34015764)

  • 1. Circular RNA ABCB10 contributes to laryngeal squamous cell carcinoma (LSCC) progression by modulating the miR-588/CXCR4 axis.
    Zhao J; Li XD; Wang M; Song LN; Zhao MJ
    Aging (Albany NY); 2021 May; 13(10):14078-14087. PubMed ID: 34015764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal regulation of miR-1205 and E2F1 modulates progression of laryngeal squamous cell carcinoma.
    Li P; Lin XJ; Yang Y; Yang AK; Di JM; Jiang QW; Huang JR; Yuan ML; Xing ZH; Wei MN; Li Y; Yuan XH; Shi Z; Liu H; Ye J
    Cell Death Dis; 2019 Dec; 10(12):916. PubMed ID: 31801947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circ_0023028 contributes to the progression of laryngeal squamous cell carcinoma by upregulating LASP1 through miR-486-3p.
    Zheng Y; Duan L; Yang Y; Luo D; Yan B
    Mol Cell Biochem; 2021 Aug; 476(8):2951-2961. PubMed ID: 33755879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of circRNA_100290 promotes the progression of laryngeal squamous cell carcinoma through the miR-136-5p/RAP2C axis.
    Wang Z; Huang C; Zhang A; Lu C; Liu L
    Biomed Pharmacother; 2020 May; 125():109874. PubMed ID: 32014687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-139 targets CXCR4 and inhibits the proliferation and metastasis of laryngeal squamous carcinoma cells.
    Luo HN; Wang ZH; Sheng Y; Zhang Q; Yan J; Hou J; Zhu K; Cheng Y; Xu YL; Zhang XH; Xu M; Ren XY
    Med Oncol; 2014 Jan; 31(1):789. PubMed ID: 24318902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.
    Jili S; Eryong L; Lijuan L; Chao Z
    Cell Biochem Funct; 2016 Dec; 34(8):597-605. PubMed ID: 27859417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA ABCB10 promotes non-small cell lung cancer progression by increasing E2F5 expression through sponging miR-584-5p.
    Ma D; Qin Y; Huang C; Chen Y; Han Z; Zhou X; Liu H
    Cell Cycle; 2020 Jul; 19(13):1611-1620. PubMed ID: 32420810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
    Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
    Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA circCORO1C promotes laryngeal squamous cell carcinoma progression by modulating the let-7c-5p/PBX3 axis.
    Wu Y; Zhang Y; Zheng X; Dai F; Lu Y; Dai L; Niu M; Guo H; Li W; Xue X; Bo Y; Guo Y; Qin J; Qin Y; Liu H; Zhang Y; Yang T; Li L; Zhang L; Hou R; Wen S; An C; Li H; Xu W; Gao W
    Mol Cancer; 2020 Jun; 19(1):99. PubMed ID: 32487167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of laryngeal squamous cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis.
    Wu T; Qu L; He G; Tian L; Li L; Zhou H; Jin Q; Ren J; Wang Y; Wang J; Kan X; Liu M; Shen J; Guo M; Sun Y
    Oncotarget; 2016 Mar; 7(10):11553-66. PubMed ID: 26872375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsa_circ_0042666 inhibits proliferation and invasion via regulating miR-223/TGFBR3 axis in laryngeal squamous cell carcinoma.
    Wei Z; Chang K; Fan C
    Biomed Pharmacother; 2019 Nov; 119():109365. PubMed ID: 31525642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA ZNF609 promotes laryngeal squamous cell carcinoma progression by upregulating epidermal growth factor receptor via sponging microRNA-134-5p.
    Yin X; Wang J; Shan C; Jia Q; Bian Y; Zhang H
    Bioengineered; 2022 Mar; 13(3):6929-6941. PubMed ID: 35236250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of laryngeal squamous cell cancer progression by the lncRNA RP11-159K7.2/miR-206/DNMT3A axis.
    Wang X; Yu B; Jin Q; Zhang J; Yan B; Yang L; Li Y; Li Q; Wang P; Sun C; Liu M; Tian L; Sun Y
    J Cell Mol Med; 2020 Jun; 24(12):6781-6795. PubMed ID: 32363688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircRASSF2 promotes laryngeal squamous cell carcinoma progression by regulating the miR-302b-3p/IGF-1R axis.
    Tian L; Cao J; Jiao H; Zhang J; Ren X; Liu X; Liu M; Sun Y
    Clin Sci (Lond); 2019 May; 133(9):1053-1066. PubMed ID: 30992382
    [No Abstract]   [Full Text] [Related]  

  • 15. Long noncoding RNA PVT1 promotes laryngeal squamous cell carcinoma development by acting as a molecular sponge to regulate miR-519d-3p.
    Zheng X; Zhao K; Liu T; Liu L; Zhou C; Xu M
    J Cell Biochem; 2019 Mar; 120(3):3911-3921. PubMed ID: 30304557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-205 suppresses proliferation and promotes apoptosis in laryngeal squamous cell carcinoma.
    Tian L; Zhang J; Ge J; Xiao H; Lu J; Fu S; Liu M; Sun Y
    Med Oncol; 2014 Jan; 31(1):785. PubMed ID: 24297308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-125b-5p suppressed the glycolysis of laryngeal squamous cell carcinoma by down-regulating hexokinase-2.
    Hui L; Zhang J; Guo X
    Biomed Pharmacother; 2018 Jul; 103():1194-1201. PubMed ID: 29864898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA MYLK serves as an oncogene to promote cancer progression via microRNA-195/cyclin D1 axis in laryngeal squamous cell carcinoma.
    Duan X; Shen N; Chen J; Wang J; Zhu Q; Zhai Z
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31427478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA MNX1-AS1 Contributes to Laryngeal Squamous Cell Carcinoma Growth and Migration by Regulating mir-744-5p/bcl9/β-Catenin Axis.
    Ma B; Ren G; Xu J; Yin C; Shi Y
    Cell Transplant; 2021; 30():9636897211005682. PubMed ID: 33821684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
    Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS
    Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.